MedTrace Logo

Ceftaroline in the Treatment of Bone and Joint Infections

NCT02005068 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2014-08-07

No results posted yet for this study

Summary

This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.

Conditions

  • Osteomyelitis
  • Joint Infections

Interventions

DRUG

Ceftaroline

The duration of treatment will vary based on type of infection (acute osteomyelitis or joint infection) and if MRSA positive or negative.

Sponsors & Collaborators

  • Forest Laboratories

    collaborator INDUSTRY

  • Orlando Health, Inc.

    lead OTHER

Principal Investigators

  • Mark R. Wallace, MD · Orlando Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02005068 on ClinicalTrials.gov